Advisors Management Group’s Novavax NVAX Stock Holding History

Advisors Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$1.43M	–	134
2021 Q4	$1.43M	Sell	10,000 -1,000	-9%	-$172K	0.43%	55
2021 Q3	$2.28M	Sell	11,000 -1,021	-8%	-$225K	0.71%	46
2021 Q2	$2.55M	Sell	12,021 -679	-5%	-$124K	0.76%	45
2021 Q1	$2.3M	Sell	12,700 -3,300	-21%	-$658K	0.72%	47
2020 Q4	$1.78M	Hold	16,000	–	–	0.73%	45
2020 Q3	$1.73M	Buy	+16,000	New	+$1.95M	0.72%	45

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisors Management Group's NVAX Position: Q1 2022 in Review

Advisors Management Group sold out of Novavax (NVAX) in Q1 2022, closing a stake of 10,000 shares — an estimated $1.43M sold.

Advisors Management Group first reported a position in NVAX in Q3 2020 and held it in 6 quarters. The position peaked at $2.55M in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

Advisors Management Group reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
Advisors Management Group sold 10,000 Novavax shares in Q1 2022, an estimated $1.43M.
Advisors Management Group first reported a position in Novavax in Q3 2020 and held it in 6 quarters.
Advisors Management Group's Novavax position peaked at $2.55M in Q2 2021.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Advisors Management Group's 13F filing for Q1 2022, filed 20 Apr 2022.